Current prostate cancer (PCa) diagnosis based on prostate-specific antigen (PSA) has been gradually losing its credibility over the last decade due to contradictory results in published literature and clinical practice. Recently, a group of potential PCa biomarkers in urine, particularly sarcosine, was found to increase significantly as the cancer progressed to metastasis. In Chapter 2, we report a simple, robust, and reproducible capillary electrophoresis–electrospray ionization–tandem mass spectrometry (CE–ESI-MS/MS) method for the determination of sarcosine and other representative potential biomarkers in pooled urine. A solid phase extraction (SPE) technique was optimized for maximum recovery of sarcosine. With no derivatization step...
The aim of this pilot study is to evaluate sarcosine, uracil, and kynurenic acid in urine as potenti...
Prostate cancer (PCa) is the most frequently diagnosed cancer and the second leading cause of cancer...
Introduction & Objectives: High-throughput analysis of low-molecular-weight metabolites, repres...
Current prostate cancer (PCa) diagnosis based on prostate-specific antigen (PSA) has been gradually ...
The current prostate cancer (PCa) diagnosis, based on the blood prostate-specific antigen (PSA) leve...
Targeted and untargeted analyses of the sub-5 kDa urine metabolome of genitourinary cancer patients ...
While sarcosine was recently identified as a potential urine biomarker for prostate cancer, further ...
Sarcosine, an isomer of L-alanine, has been proposed as a prostate cancer progression biomarker [1]....
There has been recent interest in metabolite concentrations present in urine for noninvasive disease...
Capillary electrochromatography (CEC) is a major capillary electrophoresis (CE) mode that have been ...
Shortly after sarcosine was delineated as a potential biomarker for prostate cancer in 2009, a varie...
Prostate cancer (CaP) is the most common type of tumour disease in men. Early diagnosis of cancer o...
Prostate cancer is the second most frequently diagnosed cancer in men worldwide. Currently prostate ...
A fully automated, non invasive, rapid and high-throughput method for the direct determination of sa...
An enzyme-coupled colorimetric assay for quantification of urinary sarcosine was developed. The prop...
The aim of this pilot study is to evaluate sarcosine, uracil, and kynurenic acid in urine as potenti...
Prostate cancer (PCa) is the most frequently diagnosed cancer and the second leading cause of cancer...
Introduction & Objectives: High-throughput analysis of low-molecular-weight metabolites, repres...
Current prostate cancer (PCa) diagnosis based on prostate-specific antigen (PSA) has been gradually ...
The current prostate cancer (PCa) diagnosis, based on the blood prostate-specific antigen (PSA) leve...
Targeted and untargeted analyses of the sub-5 kDa urine metabolome of genitourinary cancer patients ...
While sarcosine was recently identified as a potential urine biomarker for prostate cancer, further ...
Sarcosine, an isomer of L-alanine, has been proposed as a prostate cancer progression biomarker [1]....
There has been recent interest in metabolite concentrations present in urine for noninvasive disease...
Capillary electrochromatography (CEC) is a major capillary electrophoresis (CE) mode that have been ...
Shortly after sarcosine was delineated as a potential biomarker for prostate cancer in 2009, a varie...
Prostate cancer (CaP) is the most common type of tumour disease in men. Early diagnosis of cancer o...
Prostate cancer is the second most frequently diagnosed cancer in men worldwide. Currently prostate ...
A fully automated, non invasive, rapid and high-throughput method for the direct determination of sa...
An enzyme-coupled colorimetric assay for quantification of urinary sarcosine was developed. The prop...
The aim of this pilot study is to evaluate sarcosine, uracil, and kynurenic acid in urine as potenti...
Prostate cancer (PCa) is the most frequently diagnosed cancer and the second leading cause of cancer...
Introduction & Objectives: High-throughput analysis of low-molecular-weight metabolites, repres...